FCM
CME icon

Fourpath Capital Management’s CME Group CME Stock Holding History

Fourpath Capital Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.66M Buy
19,165
+1,202
+7% +$357K 0.81% 30
2025
Q4 		$4.91M Buy
17,963
+2,366
+15% +$643K 0.67% 37
2025
Q3 		$4.21M Sell
15,597
-75
-0.5% -$20.4K 0.6% 46
2025
Q2 		$4.32M Sell
15,672
-196
-1% -$53.3K 0.68% 39
2025
Q1 		$4.21M Sell
15,868
-75
-0.5% -$18.5K 0.73% 39
2024
Q4 		$3.7M Sell
15,943
-453
-3% -$104K 0.69% 44
2024
Q3 		$3.62M Buy
+16,396
New +$3.39M 0.67% 46

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fourpath Capital Management's CME Position: Q1 2026 in Review

Fourpath Capital Management increased its CME Group (CME) stake by 6.7% in Q1 2026, buying an estimated $357K and bringing the position to 19,165 shares worth $5.66M. The position accounts for 0.81% of the portfolio, ranked #30.

Fourpath Capital Management first reported a position in CME in Q3 2024 and has held it in 7 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Fourpath Capital Management held 19,165 shares of CME Group worth $5.66M as of Q1 2026.
  • Fourpath Capital Management bought 1,202 CME Group shares in Q1 2026, an estimated $357K.
  • CME Group made up 0.81% of Fourpath Capital Management's portfolio in Q1 2026, its #30 holding.
  • Fourpath Capital Management first reported a position in CME Group in Q3 2024 and has held it in 7 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Fourpath Capital Management's 13F filing for Q1 2026, filed 1 May 2026.